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ABSTRACT: The triadin isoforms Trisk 95 and Trisk 51 are both components of the skeletal muscle calcium
release complex. To investigate the specific role of Trisk 95 and Trisk 51 isoforms in muscle physiology, we
overexpressed Trisk 95 or Trisk 51 using adenovirus-mediated gene transfer in skeletal muscle of newborn
mice. Overexpression of either Trisk 95 or Trisk 51 alters the muscle fiber morphology, while leaving un-
changed the expression of the ryanodine receptor, the dihydropyridine receptor, and calsequestrin. We also
observe an aberrant expression of caveolin 3 in both Trisk 95- and Trisk 51-overexpressing skeletal muscles.
Using a biochemical approach, we demonstrate that caveolin 3 is associated with the calcium release complex
in skeletal muscle. Taking advantage of muscle and non-muscle cell culture models and triadin null mouse
skeletal muscle, we further dissect the molecular organization of the caveolin 3-containing calcium release
complex. Our data demonstrate that the association of caveolin 3 with the calcium release complex occurs via
a direct interaction with the transmembrane domain of the ryanodine receptor. Taken together, these data
suggest that caveolin 3-containing membrane domains and the calcium release complex are functionally
linked and that Trisk 95 and Trisk 51 are instrumental to the regulation of this interaction, the integrity of
which may be crucial for muscle physiology.
In skeletal muscle, the excitation-contraction (EC)
1 coupling
process takes place at the triads where T-tubules and the re-
ticulum sarcoplasmic terminal cisternae are in close contact. EC
couplingrequirestheexpressionatthetriadsofamultimericcalc-
ium release complex (CRC) that includes the T-tubule voltage-
dependent calcium channel dihydropyridine receptor (DHPR)
and several sarcoplasmic proteins, namely, the calcium release
channel ryanodine receptor (RyR) (1, 2), the sarcoluminal Ca
2þ
bindingcalsequestrin(CSQ),andtwoofthefourtriadinisoforms
identified to date in skeletal muscle, Trisk 95 (T95) and Trisk 51
(T51) (3, 4). In vitro studies had identified a couple of regulatory
RyR binding domains on triadin, and these regions are common
to both Trisk 95 and Trisk 51 (5, 6). Adenoviral-mediated over-
expression of either Trisk 95 or Trisk 51 in primary cultures of
skeletal muscle further demonstrated that only Trisk 95 plays
a role in the regulation of the depolarization-induced calcium
releasemechanism(4),suggestingaspecificroleofTrisk95inEC
coupling.Interestingly,triadinnullmiceexhibitastructuralmyo-
pathy (7) with impaired depolarization-induced calcium release
(7, 8) indicating that the triadins are likely to be involved in the
development of human myopathies for which a causative gene
has not yet been identified. However, no modification has been
yetidentifiedinhumantriadins,bothTrisk95andTrisk51being
expressed in human skeletal muscle (9), and it is currently
unknownwhetheroverexpressionofTrisk95andTrisk51would
be detrimental for muscle function in vivo.
In this study, we use adenovirus-mediated gene transfer to
overexpress Trisk 95 or Trisk 51 in mouse skeletal muscle as an
alternative approachtoinvestigatingthe functionofthesetriadin
isoforms. Herein, we show that overexpression of either Trisk 95
or Trisk 51 alters the muscle fiber morphology while leaving the
expression of RyR, DHPR, and CSQ unchanged. We also
observethatcaveolin3(Cav-3),anessentialstructuralcomponent
of caveolae involved in endocytosis and intracellular trafficking
events(10),isaberrantlyexpressedinbothTrisk95-andTrisk51-
overexpressing skeletal muscles. We further demonstrate that
Cav-3 is associated with the CRC via a direct interaction with the
RyR, and we propose that the Trisk 95 and Trisk 51 level of
expression is critical for the regulation of this interaction.
MATERIALS AND METHODS
Animals. Wild-type mice (C57BL/6) were bred at the Univer-
sity of Iowa from stocks originally obtained from Jackson Labo-
ratories(BarHarbor,ME).Triadinnullmicehavebeendescribed
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previously(7)andwerebredandmaintainedonaC57BL/6back-
ground at Universit  e Joseph Fourier. Animal care and proced-
ures were approvedand performedinaccordance with the stand-
ardssetforthbytheInstitutionalEthicsCommittee,theNational
Research Council Guide for the care and use of laboratory ani-
mals,theNationalInstitutesofHealth,andtheAnimalCareUse
and Review Committee of the University of Iowa.
PreparationofAntibodiesandMicrosomes.mAbsagainst
CSQ (clone VIIID12, Affinity BioReagents) and Cav-3 (BD
Transduction Laboratories) were used as described in the com-
pany datasheet. The sheep anti-DHPR R1 subunit was obtained
from Upstate Biotechnology. Polyclonal antibodies against the
RyR,thecommonN-terminalendoftradins,Trisk95,andTrisk
51 were described previously (2, 3, 11). Guinea pig anti-Ca
2þ-
ATPase was a gift from A. M. Lompr  e( 12). Crude microsomes
werepreparedfrom1-month-oldmousegastrocnemiusmuscleas
previously described (13).
Viruses. The viruses were engineered and produced by the
GeneVectorProductionNetwork,atGenethonIII(Evry,France).
Three type 5 adenoviruses were used in this study, a control virus
(AdV-DsRed) with the cDNA of the red fluorescent protein
(DsRed), AdV-Trisk 95, an adenovirus with the full-length seq-
uence of rat skeletal muscle T95 (EMBL AJ243304, 687 amino
acids), and AdV-Trisk 51, an adenovirus with the full-length
sequenceofratskeletalmuscleT51(EMBLAJ243303,461amino
acids). All the transgenes were under the control of a CMV
promoter.
In Vivo Infection. Injections of adenovirus into 3-4-day-old
wild-type pups were performed as previouslydescribed (14),with
some modification: the hamstring, quadriceps, calf, and tibialis
anterior muscles of one leg were each injected percutaneously
with 10
10 pfu diluted in 10 μL of saline; the same muscles of the
contralateral leg were eachinjectedwith anequalvolumeof saline.
Pups were reintroduced to the mother and kept in quarantine for
5 days. All pups survived after injections. Muscles were harvested
30 days after injection, snap-frozen in liquid nitrogen-cooled
isopentane, and stored at -80  C until they were used.
Cell Culture and Cell Infection. Rat myogenic L6 cells
(clone C5) or COS-7 cells were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum
(Invitrogen) and 1% penicillin-streptomycin. L6 cells were infec-
ted at a multiplicity of infection (MOI) of 200 with the adenovir-
usesencodingT95(AdV-Trisk95) orencodingT51(AdV-Trisk51).
The cells were collected 48 h after infection.
Plasmids and Transfection. The transmembrane domain of
humanRyR1(GenBankaccessionnumberJ05200)corresponding
to amino acids 4457-5038 was cloned in pEGFP-C1 (Clontech),
to produce a 93 kDa fusion protein corresponding to the GFP
fused with the channel part of RyR1. Human caveolin 3 (Gen-
Bank accession number AF036365) was cloned in pCDNA3.1
(Invitrogen). COS-7 cells were transfected with the two plasmids
(2.5 μg ofeach plasmidfor8   10
5 cells) using ExGen500 (Euro-
medex), and the cells were collected 24 h after transfection.
Immunoprecipitation. Five hundred micrograms of micro-
somes from rat skeletal muscle or 300 μg of cells was solubilized
at 2 mg/mL in the presence of 1.6% CHAPS, 0.9 M NaCl, 0.1%
phospholipids, 100 μMC a C l 2,5 0μM EGTA, 20 mM Pipes
(pH 7.1), and protease inhibitors (1 mM diisopropyl fluoropho-
sphates and 100 μM phenylmethanesulfonyl fluoride), and im-
munoprecipitation was performed with antibodies against rat
Trisk 95, rat Trisk 51, or nonimmune serum as described previ-
ously(2),using10mgofproteinAimmobilizedonSepharose4B.
All the immunoprecipitated proteins were then analyzed by
Western blotting.
WesternBlot.ThepresenceofRyR,DHPR,Trisk95,Trisk51,
calsequestrin, Ca
2þ-ATPase SERCA, or caveolin 3 in dif-
ferent samples was assayed by Western blotting, using a chemi-
luminescent reagent (Western lightning Chemiluminescence re-
agent plus, PerkinElmer Life Science). After electrophoretic
separationona5-15%acrylamidegel,theproteinswereelectro-
transferredtoImmobilonP(Millipore)aspreviouslydescribed(3).
The secondary antibodies were labeled with horseradish per-
oxidase (Jackson ImmunoResearch Laboratories). Quantitative
analysis was performed using a Chemidoc XRS and Quantity
One (Bio-Rad), and the amount of each protein was normalized
to the amount in AdV-DsRed-infected muscles, after loading
correction by Coomassie blue staining of myosin, as described
previously (15).
Immunofluorescence and Histological Analyses. Seven
micrometer cryosections were prepared and analyzed by immu-
nofluorescenceorH&Estainingaspreviouslydescribed(16).For
immunofluorescent staining, sections were washed with phos-
phate-buffered saline (PBS), blocked with 3% bovine serum
albumin(BSA)inPBSfor30minatroomtemperature,andincu-
bated with a primary antibody in a PBS/1% BSA mixture over-
night at 4  C. After incubation for 1 h at room temperature with
an Alexa fluor 488-conjugated (Invitrogen) or Cy3-conjugated
secondaryantibodyina PBS/1% BSA mixture, the samples were
mounted with PermaFluor (Beckman Coulter). Sections were
observedunderanMRC-600laserscanningconfocalmicroscope
(Bio-Rad). Digitized images were captured under identical con-
ditions. Images of H&E staining were photographed using a
Leica DM RXA microscope equipped with an Olympus DP70
digital camera.
RESULTS
Effect of Trisk 95 and Trisk 51 Overexpression on the
Expression of the CRC Components. Trisk 95 and Trisk 51,
the two major skeletal muscle triadin isoforms, were overex-
pressed in vivo using injection of adenovirus into newborn mice.
As a control, the muscles were injected with an adenovirus en-
coding DsRed. To determine the effect of Trisk 95 or Trisk 51
overexpression on the expression of their calcium release com-
plex’s partners, immunoblot analysis of crude muscle extracts
was conducted 30 days after gene transfer (Figure 1A,B). Protein
expression levels were normalized to the amounts measured in
control muscles infected with AdV-DsRed (Figure 1A, lane 3).
BothTrisk95andTrisk51wereoverexpressedby60%(Figure1A,
lanes 1 and 2, and Figure 1B), but the expression levels of the RyR,
the R1 subunit of DHPR, CSQ, and SERCA were not changed
(Figure 1B). This experiment was conducted on muscles from
different animals, with similar results (no modification of the
expression level of the proteins assayed, except for that of the
overexpressed triadin). Nevertheless, the level of overexpression
depends on the infection level, which is not identical among all
the animals. Using Western blot on muscle homogenate, the
infectedfibersaremixedwithnoninfectedfibers,whichconstitute
the majority of the fibers. To discriminate between infected and
noninfected fibers and to evaluate more precisely the modification
induced on the other proteins, we chose to analyze the expression
of the CRC components in Trisk 95- and Trisk 51-overexpressing
muscles by immunofluorescence. While the stainings for RyR,
DHPR, and CSQ were unchanged in Trisk 95-infected fibers,6132 Biochemistry, Vol. 49, No. 29, 2010 Vassilopoulos et al.
we could observe a reduction in the level of Trisk 51 expres-
sion in Trisk 95-infected fibers (Figure 1C), an effect that was
not observed in a Western blot. Likewise, only the level of
Trisk 95 expression was reduced in Trisk 51-infected fibers
(Figure 1D).
Effect of Trisk 95 and Trisk 51 Overexpression on the
Muscle Histology. Histological analysis revealed no sign of
muscle damage in control skeletal muscles injected with either
saline (data not shown) or AdV-DsRed (Figure 2A, panel a).
However, Trisk 95- and Trisk 51-infected skeletal muscles were
characterized by the presence of fibrotic tissue, atrophic fibers,
andregenerating fibers(Figure 2A, panels b andc). The extentof
muscle damage was greater in T51-infected muscles than in T95-
infected muscle, as assessed by the increased level of fibrosis and
the presence of necrotic fibers. To specifically characterize Trisk
95- and Trisk 51-infected fibers, muscle sections were analyzed
after immunostaining with caveolin 3 (Cav-3) as a plasma mem-
brane marker (Figure 2B). In contrast to muscles infected with
AdV-DsRed (Figure 2B, panels a-c and g-i), membrane stain-
ing revealed that the size of fibers infected by AdV-Trisk 95 and
AdV-Trisk 51 was abnormal. Trisk 95-infected fibers were
smaller than noninfected fibers (Figure 2B, panels d-f), and
Trisk51-infectedfibershadaroundshape(Figure2B,panelsj-l)
and lost the contact between them. In contrast with the control
AdV-DsRed-infected fibers (Figure 2B, insets), the expression
patternofCav-3wasalteredinfibersoverexpressingTrisk95and
Trisk 51. In these latter fibers, Cav-3 was shown to accumulate
intracellularly and to colocalize with the triadins. As Cav-3 is
expressed during the differentiation of the satellite cells in
myotubes(17),itcouldbehypothesizedthattheaberrantstaining
of Cav-3 specifically occurs in regenerating fibers. However,
stainingofnucleiindicatedthatnoneofthecellsdisplayingan
intracellular staining of Cav-3 were regenerating cells (data not
shown).Immunoblot analysis showed a similaramountofCav-3
in crudeextracts ofinfected muscleas compared to controlsamples
from DsRed-infected muscles (Figure 2C,D), suggesting most pro-
bably a relocalization of Cav-3 upon triadin overexpression.
Association of Cav-3 withthe Component ofthe Skeletal
Muscle CRC. In vivo modification of triadin expression results
in modification of Cav-3, indicating a functional link between
FIGURE 1: Western blot and immunofluorescent analysis of the proteins of the calcium release complex in infected muscles. The experiments
presented in panels A and B correspond to one representative experiment, which have been performed on three different infected muscles. The
valueshavenotbeenaveragedamongalltheexperimentsastheinfectionlevelisnotidenticalamongalltheinfectedmuscles.(A)Expressionofthe
components of the calcium release complex in skeletal muscle microsomes (20 μg) in Trisk 95-infected muscle (lane 1), Trisk 51-infected muscle
(lane2),orcontrolDsRed-infectedmuscle(lane3)asdeterminedbyWesternblotting.(B)LevelofproteinsexpressedasafoldofcontrolDsRed-
infectedmuscles,afterloadingcorrectionusingaquantityofmyosinestimatedbyCoomassiebluestaining.Thequantificationwasperformedon
the Western blot presented in panel A. (C) Effect of Trisk 95 overexpression on proteins of the calcium release complex. Double
immunofluorescent labeling was performed on transversal sections of muscle infected with AdV-T95 for 30 days, using antibodies directed
againstT95andtheR1ssubunitoftheDHPR(a-c),Trisk95andtheRyR(d-f),T95andCSQ(g-i),orT95andT51(j-l).Thescalebaris15μm.
(D) Effect of Trisk 51 overexpression on proteins of the calcium release complex. Double immunofluorescent labeling was performed on
transversal sections of muscle infected with AdV-T51 for 30 days using antibodies directed against T51 and the R1s subunit of the DHPR (a-c),
T51 and the RyR (d-f), T51 and CSQ (g-i), or T51 and T95 (j-l). The scale bar is 15 μm.Article Biochemistry, Vol. 49, No. 29, 2010 6133
the two proteins. We studied their possible association by
immunoprecipitation in rat skeletal muscle (Figure 3A). Using
isoform specific antibodies, both Trisk 95 and Trisk 51 co-
immunoprecipitated Cav-3 (Figure 3A, lanes 2 and 3). Trisk 95
and Trisk 51 also co-immunoprecipitated each other and the
RyR, which indicates that Cav-3 is associated with the CRC.
AnassociationbetweentheDHPRandCav-3wasproposedin
skeletal muscle (18) and shown in cardiac muscle (19). Thus, it is
possible that the molecular complex between the triadins and
Cav-3 requires a direct interaction of Cav-3 with the DHPR. To
testthe directinteractionbetween the DHPR andCav-3, weana-
lyzed the co-immunoprecipitation in rat skeletal muscle of Cav-3
with DHPR or the triadins (Figure 3A). The DHPR efficiently
co-immunoprecipitated Cav-3 and the RyR (Figure 3A, lane 5),
but not the triadins. Conversely, both Trisk 95 and Trisk 51 co-
immunoprecipitated Cav-3 but not the DHPR (Figure 3A,
lanes 2 and 3), suggesting that the association of triadin and
Cav-3 is not DHPR-dependent.
To test whether Cav-3 and the triadins are able to associate
directly, we studied their association in the L6 rat muscle cell line
that does not express the known CRC proteins but expresses
Cav-3. L6 cells were infected with AdV-Trisk 95 or AdV-Trisk
51 to induce the expression of each triadin isoform (Figure 3B,
lanes 2-4). The absence of the RyR and the presence of Cav-3
were confirmed in these cells (Figure 3B, lanes 2-4). Direct
association of Cav-3 with either triadin was studied by co-
immunoprecipitation with the anti-T95 and anti-T51 antibodies.
Although Trisk 95 and Trisk 51 were efficiently immunoprecipi-
tated, Cav-3 was co-immunoprecipitated with none (Figure 3B,
lanes 5-7), indicating that Cav-3 is not engaged in a direct
interactionwithanyof the triadins.Asboth triadins are linked in
skeletal muscle, as demonstrated by their co-immunoprecipita-
tion (Figure 3A), it is possible that the simultaneous presence of
Trisk 95 and Trisk 51 is required for association with Cav-3. To
test this hypothesis, L6 cells were co-infected with Adv-Trisk 95
and AdV-Trisk 51. However, Cav-3 was not co-immunoprecipi-
tated with either anti-triadin isoform antibody (data not shown),
suggesting that the presence of the two isoforms is not sufficient
for the association with Cav-3
RyR1 Is Associated with Cav-3. An association between
RyR2 and Cav-3 was shown in cardiac muscle (20). To test
whetherCav-3directlyinteractswithRyR1inskeletalmuscle,we
tookadvantageofthetriadinnullmousemodel(7)toanalyzethe
co-immunoprecipitation of Cav-3 with RyR1 in the absence of
triadin. Asshown in Figure 4A, Cav-3 was efficiently co-immun-
oprecipitated with the RyR in both WT (Figure 4A, lane 1) and
triadin null skeletal muscle microsomes (Figure 4A, lane 3), de-
monstrating that triadin was not necessary for this association
and that the RyR-Cav-3interactioncouldbe direct. Toconfirm
thedirectinteractionoftheRyRandCav-3,immunoprecipitation
FIGURE 2: Alterationofmusclemorphologyininfectedmuscles. (A)
Histological analysis by Hematoxylin-eosin staining of gastrocne-
mius infected for 30 days with AdV-DsRed (CTRL, panel a), AdV-
Trisk95(infT95,panelb),orAdV-Trisk51(infT51,panelc).Onlyin
muscle infected with T95 or T51 is the presence of fibrotic tissue
observed, as well as a few atrophic fibers (asterisks), necrotic fibers
stained in pink (inf T51 only), and a few regenerating fibers, cha-
racterized by their centrally located nuclei (arrows). The scale bar is
50 μm. (B) Double immunofluorescent labeling with anti-Cav-3 and
anti-T95 antibodies (a-f) or anti-Cav-3 and anti-T51 (g-l) antibo-
dies was performed on muscle sections from CTRL DsRed-infected
muscle (a-ca n dg -i), T95-infected muscle (d-f), or T51-infected
muscle (j-l). Cav-3 and T95 (insetsofpanels a-ca n dd -f) orCav-3
andT51(insetsofpanelsg-ian dj-l)intracellularstainingwascom-
paredbyconfocalmicroscopy.(C)TheexpressionlevelofCav-3was
analyzed by Western blotting on T95-infected muscle (lane 1), T51-
infected muscle (lane 2), or DsRed-infected muscle (lane 3). Five
micrograms of mouse skeletal microsomes was loaded in each lane.
(D) The quantification of the amount of caveolin 3 in each lane of
panelCwasperformed,andtheresultswerecomparedtotheamount
in DsRed-infected muscle (CTRL), after correction of loading by
myosin quantification.
FIGURE 3: Association of Cav-3 with the CRC and the triadins. (A)
Co-immunoprecipitation on rat skeletal muscle. Immunoprecipita-
tion was performed on 500 μg of rat skeletal muscle with antibodies
against Trisk 95 (lane 2), with antibodies against Trisk 51 (lane 3),
withpreimmuneserum(lane4),orwithantibodiesagainsttheDHPR
(lane 5). The immunoprecipitated proteins were then analyzed by
Western blotting with antibodies against the RyR, against the
DHPR, against the N-terminal end of triadin, or against Cav-3.
Lane1contained5μgofratskeletalmusclemicrosomesasacontrol.
(B) Co-immunoprecipitation in L6 cells. Immunoprecipitation was
performed on 300 μg of Trisk 95-infected cells (lane 2), Trisk 51-
infectedcells(lane3),orcontrolcells(lane4),withantibodiesspecific
forT95orT51.Theimmunoprecipitatedproteinswerethenanalyzed
byWesternblotting(lanes5-8)withtheanti-RyR,anti-Ntertriadin,
or anti-Cav 3. Lane 1 contained 5 μg of rat skeletal muscle micro-
somes as a control. The RyR is absent from L6 cells (infected and
control, lanes 2-4) and is not co-immunoprecipited with triadin
isoforms (lanes 5-8).6134 Biochemistry, Vol. 49, No. 29, 2010 Vassilopoulos et al.
experimentswereperformedinanon-musclecellline.COS-7cells
were cotransfected either with Cav-3 and GFP-RyR transmem-
brane domain (last 582 amino acids fused in frame with GFP on
itsN-terminalpart) orwithCav-3andGFPalone.Theanti-GFP
antibody efficiently co-immunoprecipitated the RyR and Cav-3
(Figure 4B, lane 6) but failed to co-immunoprecipitate Cav-3 in
the presence of GFP alone (Figure 4B, lane 5), confirming the
direct interaction between Cav-3 and the RyR1 transmembrane
domain.
DISCUSSION
In vivo overexpression of the triadin isoform Trisk 95 or Trisk
51wasinducedbyadenoviral-mediatedgenetransferinthehind-
limbmusclesofnewbornmice.Overexpressionofonetriadiniso-
form induced a reduction in the expression level of the second
one. The different triadin isoforms are issued of the alternative
splicing of the same gene (9), and even if the mechanisms driving
the specific expression of each isoform are unknown, it is clear
that the two triadins Trisk 95 and Trisk 51 not only are always
associated together, as seen in the co-immunoprecipitation ex-
periments, but also mutually regulate their expression, to keep
thetotalamountoftriadinintheskeletalmusclealmostconstant.
The expression of the main components of the calcium release
complex, i.e., RyR, DHPR, the Ca
2þ-ATPase SERCA, and
CSQ, was not affected. However, an interesting finding of our
study was the alteration of Cav-3 expression in triadin-infected
fibers. Using a biochemical approach, we demonstrated the ex-
istence of a molecular complex, including the triadins and Cav-3.
Using differential immunoprecipitations in WT and triadin null
skeletal muscle, as well as in muscle and non-muscle cells, we
further demonstrated that Cav-3 was associated with the CRC
viaadirectinteractionwiththetransmembranedomainofRyR1.
OurdataalsosuggestthattwodifferentpopulationsofCRCexist
intheskeletalmuscletriads,oneinvolvingaDHPR-RyR-Cav-3
complex and one involving a Trisk 95-Trisk 51-RyR-Cav-3
complex, as shown in Figure 3. This could be related to the early
electronic microscopy study demonstrating that only half of the
RyR was coupled to the DHPR (1), and one could imagine that
the DHPR and triadin are mutually excluding each other in the
CRC, the RyR uncoupled to DHPR interacting with triadin.
Triadin (Trisk 95 or Trisk 51) overexpression results in an
increased level of intracellular Cav-3 staining, which is indicative
of an in vivo functional link between the two proteins. As we
cannot demonstrate Cav-3 overexpression equivalent to triadin
overexpression,thisincreasedlevelofintracellularCav-3labeling
is most probably due to Cav-3 relocalization. Our finding that
Cav-3 is functionally linked to the proteins of the CRC raises the
questionofthephysiologicalrelevanceoftheassociationbetween
the caveolae and the SR. Cav-3 was proposed to play a role in
calcium homeostasis (21-23), and previous studies showed that
theIP3RandSERCA,bothinvolvedincalciumhomeostasis(24),
were detected within the caveolae of several different cell types,
including muscle cells (21, 22) .M o r er e c e n t l y ,L ie ta l .( 24)
showed the presence of microdomains enriched in cholesterol,
sphingolipids,andCav-3intheSRmembrane.Assumingthatthe
caveolae-SR contacts are partly responsible for the control of
the cytoplasmic free Ca
2þ concentrations in very precisely de-
fined spaces (25), the CRC involving triadins could be located at
those sites. Previous studies showed that caveolae are sites of ex-
tracellular Ca
2þ entry (26) and suggested that caveolae are invol-
vedinrefillingdepletedintracellularcalciumstores,amechanism
calledstore-operatedcalciumentry(SOCE).Caveolaecouldthen
act as intermediates between the SR and the plasma membrane.
We have previously shown that Trisk 95 can modulate the
mechanism coupling the depletion of intracellular Ca
2þ stores
to extracellular Ca
2þ entry. The overexpression of Trisk 95 dec-
reases the level of this Ca
2þ entry in myotubes (27). It would
therefore be possible that the overexpression of Trisk 95 disturbs
theSOCEbyitseffectonCav-3.TherelocalizationofCav-3from
the plasma membrane to intracellular compartments follow-
ing the overexpression of Trisk 95 would directly disturb the
Ca
2þ entry by caveolae and would therefore reduce the level of
store-operated Ca
2þ entry.
BothCav-3nullmiceandtransgenic miceoverexpressingCav-3
display a dystrophic phenotype (17). A likely explanation for the
Cav-3 null mice phenotype is the alteration of the intracellular
trafficking and targeting of membrane proteins and protein
complexes, such as dysferlin (2, 28) and the dystrophin glyco-
protein complex (17). Noteworthy is the fact that Cav-3 null
skeletal muscle also exhibitsabnormal DHPRand RyR staining,
suggesting that Cav-3 is involved in triad formation during
muscle development (29, 30). Trisk 95- and Trisk 51-overexpres-
sing muscles exhibited obvious signs of pathology that included
central nucleated fibers and heterogeneous fiber sizes that
resemble those of dystrophic muscles. Given that Trisk 95 and
Trisk 51 seem to mutually regulate their expression level and
given that triadin null mice exhibit muscle weakness (7), it is
tempting to speculate that a precise expression level of the
triadins is crucial for normal muscle function (31); an excess of
triadin could be as deleterious as a lack of triadin on the muscle
physiology. However, while Trisk 95 overexpression was shown
to block EC coupling in skeletal muscle (4), Trisk 51 over-
expression has no effect on EC coupling (4). Therefore, it is
unlikely that the muscle pathology observed in triadin-over-
expressing muscle results entirely from EC coupling dysfunction.
In this context, one could speculate that Trisk 95 or Trisk 51
overexpression perturbs the traffic of proteins forming the Ca
2þ
release machinery by Cav-3 trapping, thus resulting in the ab-
normal muscle phenotype observed here. A mechanism of Cav-3
trappinghasbeenproposedforthemutantformofCav-3,P104L,
responsible for some cases of myopathy (LGMD1C) (32, 33);
therefore, this mechanism has already been shown to be respon-
sible for a pathology. Although no disease-causing mutation has
beenidentifiedyetinthetriadingene,itispossiblethatmodification
of the triadin expression level underlies a new pathophysiological
FIGURE 4: Co-immunoprecipitation of Cav-3 with the RyR. (A)
Immunoprecipitation was performed on mouse skeletal muscle from
aWTortriadinKOmousewithantibodiesagainstRyR(lanes1and3)
or with preimmune serum (lanes 2 and 4). The immunoprecipitated
proteins were then analyzed by Western blotting with antibodies
against the RyR or Cav-3. (B) Immunoprecipitation was performed
with anti-GFP antibodies on COS-7 cells cotransfected with GFP
andCav-3(lane5)orGFP-RyRandCav-3(lane6).Theimmunopre-
cipitated proteins were then analyzed by Western blotting with anti-
bodies against GFP or Cav-3.Article Biochemistry, Vol. 49, No. 29, 2010 6135
mechanism for human myopathies, possibly involving Cav-3
alteration.
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